MeiraGTx Holdings (MGTX) Other Operating Expenses (2024 - 2025)
MeiraGTx Holdings (MGTX) posted Other Operating Expenses of $30.8 million for Q4 2025, down 5.29% on a QoQ basis from $32.5 million in Q3 2025, and down 71.34% year-over-year from $107.5 million in Q4 2024.
MeiraGTx Holdings (MGTX) Other Operating Expenses (2024 - 2025) Analysis & Trends
MeiraGTx Holdings' Other Operating Expenses history runs 2 years deep, the most recent figure standing at $30.8 million for Q4 2025.
- Quarterly Other Operating Expenses fell 71.34% year-over-year to $30.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $129.6 million (up 8.48% YoY) and the FY2025 annual result came in at $129.6 million, up 8.48% from the prior year.
- Other Operating Expenses was $30.8 million for Q4 2025 at MeiraGTx Holdings, down from $32.5 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $107.5 million in Q4 2024 and bottomed at $12.0 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30.81 Mn |
| Sep 30, 2025 | 32.53 Mn |
| Jun 30, 2025 | 33.50 Mn |
| Mar 31, 2025 | 32.78 Mn |
| Dec 31, 2024 | 107.50 Mn |
| Sep 30, 2024 | 11.99 Mn |